Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung protection with dexmedetomidine in CPB-related acute lung injury
ChiCTR-IPR-17010954Phase 4Recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in acute lung injury (ALI) (4 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Hemodynamics, Interleukin-6 (IL-6) and 6 more. Started Jun 2015; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on ChiCTR-IPR-17010954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010954.